#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Systemic mastocytosis Extra-osseous Ewing's sarcoma metastatic Liposarcoma Nephropathy HER2 gene amplification Heart disease congenital Conjunctivitis allergic Small cell lung cancer Follicular lymphoma stage III Oropharyngeal cancer recurrent Cholangitis sclerosing B-cell lymphoma B-cell small lymphocytic lymphoma recurrent Progressive familial intrahepatic cholestasis Methylmalonic acidaemia More trials…

    Learn about Rare Diseases

    Retinoblastoma Acute respiratory distress syndrome – Diagnostics Mast cell activation syndrome – Trials in Disease Mantle cell lymphoma – Trials in Disease Proteus syndrome – Trials in Disease Waldenstrom’s macroglobulinaemia recurrent – Treatment Leiomyosarcoma recurrent – Trials in Disease CADASIL – Basic Information Angiosarcoma metastatic – Treatment Waldenstrom’s macroglobulinaemia recurrent More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Carbetocin Gallium (68Ga) Chloride GRAPHITE Lamivudine Perindopril Tert-Butylamine GS-248 ATTR-01 Sodium Oxybate Sacituzumab Tirumotecan Ly3556050 Ritonavir Azd8205 Cefepime Rbl027.2 Dronabinol Simoctocog Alfa Rondaptivon Pegol Surzebiclimab Ep262 Balstilimab More therapies…

    Learn about Your Condition

    Prostate cancer recurrent Corticobasal degeneration Hepatitis alcoholic Heparin resistance Von Hippel-Lindau disease Endolymphatic hydrops Osteoporosis Bone marrow failure Meningococcal infection Crigler-Najjar syndrome Mast cell activation syndrome Lymphangiosarcoma Loeys-Dietz syndrome Affective disorder Mastocytosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of momelotinib tablets in patients with anemia caused by low-risk myelodysplastic syndrome

    Recruiting

    2 1 1
    Investigated Drugs:
    • Momelotinib Dihydrochloride Monohydrate
    France Germany Italy Poland Spain

  • Study of Mosunetuzumab Treatment in Patients with Systemic Lupus Erythematosus with or without Lupus Nephritis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Mosunetuzumab
    Italy

  • Study comparing QL2107 and pembrolizumab in patients with resected non-small cell lung cancer receiving adjuvant therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Pembrolizumab
    Greece Hungary Poland Romania Spain

  • Study of cemiplimab treatment after surgery in patients with stage II-IIIA non-small cell lung cancer who have not received chemotherapy and have PD-L1 expression of 1% or higher

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Cemiplimab
    Austria Estonia France Germany Ireland Italy +1

  • Evaluation of controlled-ileal-release nicotinic acid tablets compared to placebo for treating people with prediabetes

    Recruiting

    2 1
    Germany

  • Study of evenamide as add-on treatment for patients with treatment-resistant schizophrenia not adequately controlled by current antipsychotic medications

    Recruiting

    3 1
    Investigated Diseases:
    • Schizophrenia
    Bulgaria Croatia Czechia France Germany Hungary +3
Previous Page
1 … 140 141 142 143 144 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!